✦ LIBER ✦

LIPID-ALTERING EFFICACY AND SAFETY PROFILE OF CO-ADMINISTERED EXTENDED RELEASE NIACIN/LAROPIPRANT AND SIMVASTATIN IN PATIENTS WITH DYSLIPIDEMIA

✍ Scribed by Farnier, M.; Ose, L.; Gleim, G.; Liu, N.; Thompson-Bell, S.; Beckey, K.; Johnson-Levonas, A.; Ballantyne, C.; Paolini, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SAFETY PROFILE OF EXTENDED-RELEASE NIACI

✍ McKenney, J.; Bays, H.; Koren, M.; Ballantyne, C.; Maccubbin, D.; Mitchel, Y.; B 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Effects of coadministered extended-relea

✍ Christie Ballantyne; Gilbert Gleim; Nancy Liu; Christine McCrary Sisk; Amy O. Jo 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 574 KB

Lipid-Altering Efficacy and Safety of Ez

✍ John R. Guyton; B. Greg Brown; Sergio Fazio; Adam Polis; Joanne E. Tomassini; An 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 463 KB

Efficacy and safety of combination thera

✍ William Insull Jr.; Jan N. Basile; Anthony N. Vo; Ping Jiang; Roopal Thakkar; Ro 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 270 KB

Efficacy and tolerability of extended-re

✍ Harold E. Bays; Arvind Shah; Jianxin Lin; Christine McCrary Sisk; John F. Paolin 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 278 KB

Lipid-modifying efficacy and tolerabilit

✍ D. Maccubbin; H. E. Bays; A. G. Olsson; V. Elinoff; A. Elis; Y. Mitchel; W. Sira 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB